13 NGOs question ECHA on the monitoring of anti-covid-19 nano products

.
.
.

In an open letter published online, thirteen NGOs – including AVICENN – have requested clarification from the European Chemicals Agency (ECHA) on the regulatory framework and risk management measures in place at the European level on the monitoring of anti-covid-19 nano products.

What mechanisms ensure that only authorized active substances are used on the European market? What measures are taken regarding masks treated with nanoparticles sold in Europe? Are there any plans to intensify controls and accelerate the evaluation of biocidal active substances? To be continued…

Upcoming Nano Agenda

2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
health
health
occupational health
prevention
risks
  • 8th Congress of Occupational Medicine and Health (CNMST 2026)
  • Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
  • Website: www.medecine-sante-travail.com
26
Juin
2026
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee
5
Oct.
2026
Characterizing and preventing risks related to manufactured nanomaterials and ultrafine particles (INRS, Vandœuvre-Lès-Nancy – France)
Nancy
Training
  • Training intended for occupational physicians, occupational risk prevention specialists (IPRP), company prevention specialists, prevention department staff from Carsat, Cramif and CGSS, institutional prevention specialists (Dreets, Dreal, MSA…).
  • Organizer: French National institute of research and security (INRS)
  • October 5 to 9, 2026
  • Website: www.inrs.fr/…/formation/…JA1030_2026